251 related articles for article (PubMed ID: 36854924)
1. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
Li C; Guan N; Liu F
J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
[TBL] [Abstract][Full Text] [Related]
2. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes.
Kim G; Kim M; Lee Y; Byun JW; Hwang DW; Lee M
J Control Release; 2020 Jan; 317():273-281. PubMed ID: 31730913
[TBL] [Abstract][Full Text] [Related]
3. Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma.
Liu X; Cao Z; Liu N; Gao G; Du M; Wang Y; Cheng B; Zhu M; Jia B; Pan L; Zhang W; Jiang Y; He W; Xu L; Zhang W; An Q; Guo Q; Gu J
Front Pharmacol; 2022; 13():975291. PubMed ID: 36059990
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow mesenchymal stem cell-derived exosomal microRNA-125a promotes M2 macrophage polarization in spinal cord injury by downregulating IRF5.
Chang Q; Hao Y; Wang Y; Zhou Y; Zhuo H; Zhao G
Brain Res Bull; 2021 May; 170():199-210. PubMed ID: 33609602
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
6. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
[TBL] [Abstract][Full Text] [Related]
7. Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.
Wang M; Sun Y; Gu R; Tang Y; Han G; Zhao S
J Ovarian Res; 2024 May; 17(1):101. PubMed ID: 38745186
[TBL] [Abstract][Full Text] [Related]
8. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
Liang SF; Zuo FF; Yin BC; Ye BC
Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy.
Van Woensel M; Mathivet T; Wauthoz N; Rosière R; Garg AD; Agostinis P; Mathieu V; Kiss R; Lefranc F; Boon L; Belmans J; Van Gool SW; Gerhardt H; Amighi K; De Vleeschouwer S
Sci Rep; 2017 Apr; 7(1):1217. PubMed ID: 28450700
[TBL] [Abstract][Full Text] [Related]
10. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S
J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800
[TBL] [Abstract][Full Text] [Related]
11. Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth.
Tian Y; Liu C; Li Z; Ai M; Wang B; Du K; Liu W; Wang H; Yu P; Chen C; Lin J; Xu A; Li R; Zhang W; Yuan Y
Redox Biol; 2022 Oct; 56():102454. PubMed ID: 36044789
[TBL] [Abstract][Full Text] [Related]
12. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
[TBL] [Abstract][Full Text] [Related]
13. Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against
Ni X; Wu W; Sun X; Ma J; Yu Z; He X; Cheng J; Xu P; Liu H; Shang T; Xi S; Wang J; Zhang J; Chen Z
Sci Adv; 2022 Jul; 8(27):eabl5165. PubMed ID: 35857445
[TBL] [Abstract][Full Text] [Related]
14. Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages.
Moradi-Chaleshtori M; Shojaei S; Mohammadi-Yeganeh S; Hashemi SM
Life Sci; 2021 Oct; 282():119800. PubMed ID: 34245773
[TBL] [Abstract][Full Text] [Related]
15. Delivery of High Mobility Group Box-1 siRNA Using Brain-Targeting Exosomes for Ischemic Stroke Therapy.
Kim M; Kim G; Hwang DW; Lee M
J Biomed Nanotechnol; 2019 Dec; 15(12):2401-2412. PubMed ID: 31748020
[TBL] [Abstract][Full Text] [Related]
16. Roles of the m
Yuan F; Cai X; Cong Z; Wang Y; Geng Y; Aili Y; Du C; Zhu J; Yang J; Tang C; Zhang A; Zhao S; Ma C
Front Immunol; 2022; 13():798583. PubMed ID: 35558067
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
[No Abstract] [Full Text] [Related]
18. Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
Zeng AL; Yan W; Liu YW; Wang Z; Hu Q; Nie E; Zhou X; Li R; Wang XF; Jiang T; You YP
Oncogene; 2017 Sep; 36(38):5369-5381. PubMed ID: 28504721
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
[TBL] [Abstract][Full Text] [Related]
20. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]